Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

Partnership to explore expanded cardiac screening, clinical research, and AI-assisted echocardiography in Costa Rica Toronto, Ontario – TheNewswire - April 1, 2026 – Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company ") ( TSXV: VPT; OTC: VPTDF ), a leader in AI-assisted cardiac imaging solutions, today announced a collaboration with the Health Division of the Montecristo Group to explore new clinical pathways for the implementation of Ventripoint's VMS+™ cardiac imaging platform in Costa Rica.